| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2020 | Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects | Cheng, YW; Chao, TL; Li, CL; Chiu, MF; Kao, HC; Wang, SH; Pang, YH; Lin, CH; Tsai, YM; Lee, WH; Tao, MH ; Ho, TC; Wu, PY; Jang, LT; Chen, PJ; Chang, SY; Yeh, SH | CELL REPORTS 33(2), 108254 | | | |
| 2021 | Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection | Huang, KY; Lin, MS; Kuo, TC; Chen, CL; Lin, CC; Chou, YC ; Chao, TL; Pang, YH; Kao, HC; Huang, RS; Lin, S; Chang, SY; Yang, PC | EMBO molecular medicine 13(1), e12828 | | | |
| 2021 | Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses | Chang, SY; Huang, KY; Chao, TL; Kao, HC; Pang, YH; Lu, L; Chiu, CL; Huang, HC; Cheng, TR ; Fang, JM; Yang, PC | Scientific reports 11, 8692 | | | |
| 2021 | Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 | Hsu, HY; Yang, CW; Lee, YZ; Lin, YL ; Chang, SY; Yang, RB ; Liang, JJ; Chao, TL; Liao, CC ; Kao, HC; Wu, SH; Chang, JY; Sytwu, HK; Chen, CT; Lee, SJ | Frontiers in pharmacology 12, 706901 | | | |
| 2022 | Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models | Huang, HY; Liao, HY; Chen, X; Wang, SW; Cheng, CW; Shahed-Al-Mahmud, M; Liu, YM; Mohapatra, A; Chen, TH; Lo, JM; Wu, YM; Ma, HH; Chang, YH; Tsai, HY; Chou, YC ; Hsueh, YP ; Tsai, CY ; Huang, PY; Chang, SY; Chao, TL; Kao, HC; Tsai, YM; Chen, YH ; Wu, CY ; Jan, JT ; Cheng, TR ; Lin, KI ; Ma, C ; Wong, CH | Science Translational Medicine 14(639), eabm0899 | | | |
